Related Experiment Video
Updated: Oct 30, 2025

Colon Ascendens Stent Peritonitis CASP - a Standardized Model for Polymicrobial Abdominal Sepsis
Published on: December 18, 2010
Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020
Sameer S Kadri1, Junfeng Sun1, Alexander Lawandi1
1National Institutes of Health Clinical Center, Bethesda, Maryland (S.S.K., J.S., A.L., M.K., C.Y., S.M., J.K., R.L.D., C.Y.D., S.W.).
Insights
Hospital surges in COVID-19 cases increased patient mortality risk, even as treatments improved. Supporting hospitals during surges is crucial for saving lives and overcoming challenges posed by high caseloads.
Area of Science:
- Public Health
- Epidemiology
- Healthcare Management
Background:
- Several U.S. hospitals experienced surges in COVID-19 patient numbers.
- The impact of these surges on COVID-19 survival rates, independent of other factors, was not well understood.
Purpose of the Study:
- To investigate the association between a hospital's severity-weighted COVID-19 caseload and patient mortality risk.
- To identify factors that modify this relationship.
Main Methods:
- A retrospective cohort study analyzed data from 558 U.S. hospitals between March and August 2020.
- Hospitals were stratified by a surge index, a measure of COVID-19 caseload relative to bed capacity.
- Hierarchical modeling assessed the effect of the surge index on in-hospital mortality risk.
Main Results:
- Higher surge index percentiles were associated with increased odds of COVID-19 mortality.
- The relationship between surge index and mortality was stronger during later months (June-August) despite treatment advancements.
- An estimated 23.2% of COVID-19 deaths were potentially linked to hospitals experiencing caseload surges.
Conclusions:
- Hospital COVID-19 caseload surges negatively impacted patient survival, potentially offsetting gains from improved treatments.
- Strengthening preventive measures and providing support to hospitals facing surges are vital for reducing mortality.
Background:
Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival.
Objective:
To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship.
Design:
Retrospective cohort study. (ClinicalTrials.gov: NCT04688372).
Setting:
558 U.S. hospitals in the Premier Healthcare Database.
Participants:
Adult COVID-19-coded inpatients admitted from March to August 2020 with discharge dispositions by October 2020.
Measurements:
Each hospital-month was stratified by percentile rank on a surge index (a severity-weighted measure of COVID-19 caseload relative to pre-COVID-19 bed capacity). The effect of surge index on risk-adjusted odds ratio (aOR) of in-hospital mortality or discharge to hospice was calculated using hierarchical modeling; interaction by surge attributes was assessed.
Results:
Of 144 116 inpatients with COVID-19 at 558 U.S. hospitals, 78 144 (54.2%) were admitted to hospitals in the top surge index decile. Overall, 25 344 (17.6%) died; crude COVID-19 mortality decreased over time across all surge index strata. However, compared with nonsurging (<50th surge index percentile) hospital-months, aORs in the 50th to 75th, 75th to 90th, 90th to 95th, 95th to 99th, and greater than 99th percentiles were 1.11 (95% CI, 1.01 to 1.23), 1.24 (CI, 1.12 to 1.38), 1.42 (CI, 1.27 to 1.60), 1.59 (CI, 1.41 to 1.80), and 2.00 (CI, 1.69 to 2.38), respectively. The surge index was associated with mortality across ward, intensive care unit, and intubated patients. The surge-mortality relationship was stronger in June to August than in March to May (slope difference, 0.10 [CI, 0.033 to 0.16]) despite greater corticosteroid use and more judicious intubation during later and higher-surging months. Nearly 1 in 4 COVID-19 deaths (5868 [CI, 3584 to 8171]; 23.2%) was potentially attributable to hospitals strained by surging caseload.
Limitation:
Residual confounding.
Conclusion:
Despite improvements in COVID-19 survival between March and August 2020, surges in hospital COVID-19 caseload remained detrimental to survival and potentially eroded benefits gained from emerging treatments. Bolstering preventive measures and supporting surging hospitals will save many lives.
Primary Funding Source:
Intramural Research Program of the National Institutes of Health Clinical Center, the National Institute of Allergy and Infectious Diseases, and the National Cancer Institute.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Cancer Survival Analysis
Assumptions of Survival Analysis
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...

